Effect of the BET Protein Inhibitor, RVX-208, on Progression of Coronary Atherosclerosis: Results of the Phase 2b, Randomized, Double-Blind, Multicenter, ASSURE Trial. (Q38403478)

From Wikidata

Jump to navigation Jump to search

scientific article published on 18 September 2015

Language	Label	Description	Also known as
English	Effect of the BET Protein Inhibitor, RVX-208, on Progression of Coronary Atherosclerosis: Results of the Phase 2b, Randomized, Double-Blind, Multicenter, ASSURE Trial.	scientific article published on 18 September 2015

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26385396%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Effect of the BET Protein Inhibitor, RVX-208, on Progression of Coronary Atherosclerosis: Results of the Phase 2b, Randomized, Double-Blind, Multicenter, ASSURE Trial (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26385396%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

multicenter clinical trial

0 references

atherosclerosis

1 reference

based on heuristic

inferred from title

Stephen Nicholls

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26385396%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

14

object named as

Steven E Nissen

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26385396%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

John J. P. Kastelein

7

object named as

John J P Kastelein

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26385396%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Christie M. Ballantyne

4

object named as

Christie M Ballantyne

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26385396%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

author name string

Rishi Puri

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26385396%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Kathy Wolski

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26385396%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Philip J Barter

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26385396%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

H Bryan Brewer

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26385396%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Bo Hu

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26385396%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Kiyoko Uno

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26385396%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Yu Kataoka

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26385396%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Jean-Paul R Herrman

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26385396%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Bela Merkely

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26385396%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Marilyn Borgman

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26385396%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

publication date

1 February 2016

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26385396%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

American journal of cardiovascular drugs

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26385396%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26385396%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26385396%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

55-65

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26385396%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

https://scigraph.springernature.com/pub.10.1007/s40256-015-0146-z

0 references

High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study

1 reference

https://api.crossref.org/works/10.1007%2FS40256-015-0146-Z

21 January 2018

Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy

1 reference

https://api.crossref.org/works/10.1007%2FS40256-015-0146-Z

21 January 2018

Effects of dalcetrapib in patients with a recent acute coronary syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS40256-015-0146-Z

21 January 2018

Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS40256-015-0146-Z

21 January 2018

Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS40256-015-0146-Z

21 January 2018

Efficacy and safety of a novel oral inducer of apolipoprotein a-I synthesis in statin-treated patients with stable coronary artery disease a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS40256-015-0146-Z

21 January 2018

RVX-208: a small molecule that increases apolipoprotein A-I and high-density lipoprotein cholesterol in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1007%2FS40256-015-0146-Z

21 January 2018

Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS40256-015-0146-Z

21 January 2018

Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial

1 reference

https://api.crossref.org/works/10.1007%2FS40256-015-0146-Z

21 January 2018

Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes: the PERISCOPE randomized controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS40256-015-0146-Z

21 January 2018

Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesity and coronary artery disease: the STRADIVARIUS randomized controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS40256-015-0146-Z

21 January 2018

Effect of torcetrapib on the progression of coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS40256-015-0146-Z

21 January 2018

Effect of ACAT inhibition on the progression of coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS40256-015-0146-Z

21 January 2018

Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS40256-015-0146-Z

21 January 2018

ApoA-I induction as a potential cardioprotective strategy: rationale for the SUSTAIN and ASSURE studies.

1 reference

https://api.crossref.org/works/10.1007%2FS40256-015-0146-Z

21 January 2018

Variability of area measurements obtained with different intravascular ultrasound catheter systems: Impact on clinical trials and a method for accurate calibration.

1 reference

https://api.crossref.org/works/10.1007%2FS40256-015-0146-Z

21 January 2018

Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women

1 reference

https://api.crossref.org/works/10.1007%2FS40256-015-0146-Z

21 January 2018

Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS40256-015-0146-Z

21 January 2018

Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk

1 reference

https://api.crossref.org/works/10.1007%2FS40256-015-0146-Z

21 January 2018

Intravascular ultrasound-derived measures of coronary atherosclerotic plaque burden and clinical outcome

1 reference

https://api.crossref.org/works/10.1007%2FS40256-015-0146-Z

21 January 2018

Dysfunctional HDL: a novel important diagnostic and therapeutic target in cardiovascular disease?

1 reference

https://api.crossref.org/works/10.1007%2FS40256-015-0146-Z

21 January 2018

Factors underlying regression of coronary atheroma with potent statin therapy.

1 reference

https://api.crossref.org/works/10.1007%2FS40256-015-0146-Z

21 January 2018

The forgotten majority: unfinished business in cardiovascular risk reduction

1 reference

https://api.crossref.org/works/10.1007%2FS40256-015-0146-Z

21 January 2018

Statin intolerance - an attempt at a unified definition. Position paper from an International Lipid Expert Panel

1 reference

https://api.crossref.org/works/10.1007%2FS40256-015-0146-Z

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38403478&oldid=1659221766"